Washington Capital Management Inc Laboratory Corp Of America Holdings Transaction History

Washington Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$209.01 - $232.56 $14,630 - $16,279	-70 Reduced 1.34%	5,145 $1.12 Million
Q4 2023 Jan 19, 2024	SELL	$197.69 - $227.29 $70,179 - $80,687	-355 Reduced 6.37%	5,215 $1.19 Million
Q3 2023 Oct 26, 2023	BUY	$201.05 - $221.7 $110,577 - $121,935	550 Added 10.96%	5,570 $1.12 Million
Q2 2023 Sep 18, 2023	BUY	$211.93 - $241.33 $565,853 - $644,351	2,670 Added 113.62%	5,020 $1.21 Million
Q1 2023 Sep 18, 2023	BUY	$213.32 - $257.83 $117,326 - $141,806	550 Added 30.56%	2,350 $539,000
Q3 2021 Sep 18, 2023	BUY	$274.82 - $308.34 $494,676 - $555,012	1,800 New	1,800 $506,000
Q2 2021 Aug 11, 2021	SELL	$251.87 - $278.14 $402,992 - $445,024	-1,600 Reduced 47.06%	1,800 $497,000
Q2 2020 Aug 04, 2020	BUY	$113.31 - $182.44 $45,324 - $72,976	400 Added 13.33%	3,400 $565,000
Q3 2017 Nov 09, 2017	BUY	$149.47 - $160.56 $448,410 - $481,680	3,000	3,000 $453,000

126

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Washington Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Washington Capital Management Inc with notifications on news.